SUBSEQUENT EVENTS (Details) - Subsequent Event - Collaborative Arrangement, Transaction with Party to Collaborative Arrangement - JCR Pharmaceuticals $ in Thousands	1 Months Ended
Jul. 31, 2025 USD ($)
Subsequent Event [Line Items]
Upfront payment received	$ 9,250
Future milestone payment received	555,000
Development
Subsequent Event [Line Items]
Future milestone payment received	40,000
Sales and Royalties
Subsequent Event [Line Items]
Future milestone payment received	$ 515,000

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483399/855-10-50-2

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration